Research Study

Salbutamol, Air Pollution and Breathing Mechanics

Overview

Body Locations and Systems 
Asthma
ClinicalTrials.gov# 
NCT02252302
Study Start/End 
May 1, 2015 to Sep 30, 2016
Locations 
Research Pavilion, Vancouver General Hospital
Name/Title 
Sarah Koch/Research Coordinator
Phone 
604-346-8251
Purpose of Study 

When exposed to air pollution, the asthma symptoms are aggravated and lung function is impaired. Due to high breathing rates and volumes, athletes are at particular risk of lung health impairment due to the high breathing rates and volumes. Greater doses of air pollutants reach deeper areas in the lungs where they can trigger asthma-symptoms. When treating these symptoms with inhaled beta-2-agonists the airways widen even more, allowing the air pollutants to reach even deeper areas of the lung. With this study the investigators investigate how inhaled beta-2-agonists affect athletic performance and lung health in athletes.

Eligibility 

For more information please click here.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.